Besada, E. (2014). Potential patient benefit of a subcutaneous formulation of tocilizumab for the treatment of rheumatoid arthritis: A critical review. Dove Medical Press.
Citação norma ChicagoBesada, Emilio. Potential Patient Benefit of a Subcutaneous Formulation of Tocilizumab for the Treatment of Rheumatoid Arthritis: A Critical Review. Dove Medical Press, 2014.
MLA citiranjeBesada, Emilio. Potential Patient Benefit of a Subcutaneous Formulation of Tocilizumab for the Treatment of Rheumatoid Arthritis: A Critical Review. Dove Medical Press, 2014.
Opozorilo: Ti citati niso vedno 100% točni.